Arkolith/Insider Trading/LYRA/Form 4

Waksal Harlan

Executive Chair, DirectorLyra Therapeutics, Inc. (LYRA) · full profile →Form 4 · filed Nov 13, 2023
Net Buying
Open-Market Buys
$74K
Open-Market Sells
$0
Net Open-Market Flow
$74K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 10, 2023Buy(P)25K$2.96$74K262K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-063137) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML